英文字典中文字典51ZiDian.com

中文字典辞典英文字典 a b c d e f g h i j k l m n o p q r s t u v w x y z

fuci

fucus的复数形

The Collaborative International Dictionary of English v.0.48 (gcide)

Fucus \Fu"cus\, n.; pl. {Fuci}. [L. rock lichen, orchil, used as
a red dye, red or purple color, disguise, deceit.]
1. A paint; a dye; also, false show. [Obs.]
[1913 Webster]

2. (Bot.) A genus of tough, leathery seaweeds, usually of a
dull brownish green color; rockweed.
[1913 Webster]

Note: Formerly most marine alg[ae] were called fuci.
[1913 Webster]

请选择你想看的字典辞典：

单词	字典	翻译
Fuci	查看　Fuci　在百度字典中的解释	百度英翻中〔查看〕
Fuci	查看　Fuci　在Google字典中的解释	Google英翻中〔查看〕
Fuci	查看　Fuci　在Yahoo字典中的解释	Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!

中文字典英文字典工具:

选择颜色:

<style type="text/css">#word104_1 br {display:none;}</style>
<form id="word104_1" method="post" action="http://ar.goldgoldprice.com/index.php" target="_blank">
<div style="width: 140px;border:1px solid #000;background-color:#ffffff;padding: 0px 0px;margin: 0px 0px;align:center;text-align:center;overflow:hidden;"><div id="xcolor1_1" style="font-size:12px;color:#183a00;line-height:16px;font-family: arial; font-weight:bold;background:#94abf0;padding: 3px 1px;text-align:center;"><a href="http://ar.goldgoldprice.com/" alt="英文字典中文字典" title="英文字典中文字典" id="word_name104_1" style="color:#000000;font-size:14px;text-decoration:none;line-height:16px;font-family: arial;" >英文字典中文字典</a></div><table width=100% style='align:center;text-align:left;font-size:12px;background-color:#ffffff;color:#333333;'>
<tr><td style="text-align:center;border:0"><input type=hidden name="word104_hi" value="1">输入中英文单字</td></tr><tr><td style="text-align:center;border:0"><input type="text" name="word104_input" value="" size=10 style="background-color:#ffffff;color:#000;text-decoration:none;font-family: arial;rial;border:1px solid #999;padding:1px!important;"></td></tr><tr style='line-height: 26px;'><td style="text-align:center;border:0"><input type=submit style="background-color:#ccc;color:#000;border:0 none;cursor:pointer;" value="查询字典"></td></tr></table></div>
</form>

英文字典中文字典相关资料:

Tislelizumab Combined With Induction Chemotherapy and . . .
To evaluate the efficacy and safety of adding tislelizumab to induction chemotherapy and concurrent chemoradiotherapy (CRT), with or without maintenance immunotherapy, in patients with unresectable locally advanced esophageal squamous cell carcinoma (ESCC)
Tislelizumab plus chemotherapy versus placebo plus . . .
The options for first-line treatment of advanced oesophageal squamous cell carcinoma are scarce, and the outcomes remain poor The anti-PD-1 antibody, tislelizumab, has shown antitumour activity in previously treated patients with advanced oesophageal squamous cell carcinoma We report interim analysis results from the RATIONALE-306 study, which aimed to assess tislelizumab plus chemotherapy
TEVIMBRA - accessdata. fda. gov
1 INDICATIONS AND USAGE 1 1 Esophageal Cancer First-Line Treatment of Esophageal Squamous Cell Carcinoma TEVIMBRA, in combination with platinum-containing chemotherapy, is indicated for the first-line treatment of adults with unresectable or metastatic esophageal squamous cell carcinoma (ESCC) whose tumors express PD-L1 (≥1)
ESCC and GC GEJC Treatment | TEVIMBRA® (tislelizumab-jsgr)
TEVIMBRA is a prescription medicine used to treat adults with: cancer of the tube that connects your throat to your stomach (esophageal cancer) TEVIMBRA may be used in combination with chemotherapy that contains platinum as your first treatment when your esophageal cancer: is a type called squamous cell carcinoma, and cannot be removed with surgery or has spread to other parts of the body
Oncology Drug Reference Sheet: Tislelizumab-Jsgr - ons. org
Tislelizumab-jsgr (Tevimbra®) is a programmed cell death protein-1 (PD-1) blocking antibody approved in the United States in 2024 for the treatment of certain esophageal and gastric cancers It is administered via IV and works by enhancing the immune system’s ability to target cancer cells
New First-line Treatment Option for Esophageal Cancer . . .
The FDA has approved tislelizumab-jsgr with chemotherapy to treat for certain patients with esophageal cell squamous cell carcinoma
First-Line Tislelizumab Plus Chemotherapy Approved in ESCC . . .
The FDA today approved tislelizumab (Tevimbra; BeiGene) plus chemotherapy for the first-line treatment of patients with unresectable or metastatic esophageal squamous cell carcinoma (ESCC) whose
Tislelizumab efficacy and safety compared to . . . - Frontiers
Tislelizumab efficacy and safety compared to other anti–PD-1s: a network meta-analysis of first-line therapies for unresectable, locally advanced or metastatic esophageal squamous cell carcinoma
FDA Approves First-Line Tislelizumab Plus Chemotherapy for . . .
The FDA has approved tislelizumab-jsgr plus chemotherapy for frontline use in adult patients with advanced esophageal squamous cell carcinoma and PD-L1 expression
Tislelizumab Dosage Guide + Max Dose, Adjustments - Drugs. com
Detailed Tislelizumab dosage information for adults Includes dosages for Esophageal Carcinoma and Gastric Cancer; plus renal, liver and dialysis adjustments

中文字典-英文字典 2005-2009